. "(2R,3R,4S)-4-guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid"@en . "J05" . "AH01" . "60855" . "139110-80-8" . "50663" . . "2.0"^^ . "DB00558" . "Zanamivir INN /z\u0259\u02C8n\u00E6m\u0268v\u026A\u0259r/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed."@en . "L6O3XI777I" .